Skip to main content

US ClosedU.S. Closed

ABCL: AbCellera Biologics Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

AbCellera Biologics Inc. specializes in pioneering an advanced platform for the discovery of antibodies.

52W Range

87thpctl

Volume

0.70×avg

Market Cap

3.47BUSD

P/E Ratio

-21.0TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

AbCellera Biologics Inc.

ABCLNASDAQ Global Select·USD·Closed

AbCellera Biologics Inc.

ABCLNASDAQ·USD·Closed

$11.35

−8.47%

$11.35

−$1.05 (8.47%)

52W Range

87thpctl

Volume

0.70×avg

Mkt Cap

3.47BUSD

P/E

-21.0TTM

Div Yield

–ann